These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 19481931

  • 1. Synthesis and antinociceptive activity of pyrazolyl isoxazolines and pyrazolyl isoxazoles.
    Karthikeyan K, Veenus Seelan T, Lalitha KG, Perumal PT.
    Bioorg Med Chem Lett; 2009 Jul 01; 19(13):3370-3. PubMed ID: 19481931
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of pyrazoles and isoxazoles as potent alpha(v)beta3 receptor antagonists.
    Penning TD, Khilevich A, Chen BB, Russell MA, Boys ML, Wang Y, Duffin T, Engleman VW, Finn MB, Freeman SK, Hanneke ML, Keene JL, Klover JA, Nickols GA, Nickols MA, Rader RK, Settle SL, Shannon KE, Steininger CN, Westlin MM, Westlin WF.
    Bioorg Med Chem Lett; 2006 Jun 15; 16(12):3156-61. PubMed ID: 16621534
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, antimicrobial and antioxidant activities of substituted pyrazoles, isoxazoles, pyrimidine and thioxopyrimidine derivatives.
    Padmaja A, Payani T, Reddy GD, Padmavathi V.
    Eur J Med Chem; 2009 Nov 15; 44(11):4557-66. PubMed ID: 19631423
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antimicrobial activity of (1,4-phenylene)bis(arylsulfonylpyrazoles and isoxazoles).
    Lavanya G, Mallikarjuna Reddy L, Padmavathi V, Padmaja A.
    Eur J Med Chem; 2014 Feb 12; 73():187-94. PubMed ID: 24398288
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles.
    Abdu Musad E, Mohamed R, Saeed BA, Vishwanath BS, Rai KM.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3536-40. PubMed ID: 21612921
    [Abstract] [Full Text] [Related]

  • 6. Efficient and divergent synthesis of fully substituted 1H-pyrazoles and isoxazoles from cyclopropyl oximes.
    Wang K, Xiang D, Liu J, Pan W, Dong D.
    Org Lett; 2008 May 01; 10(9):1691-4. PubMed ID: 18380466
    [Abstract] [Full Text] [Related]

  • 7. 3,5-Diphenyl-1H-pyrazole derivatives. I--Esters and N-substituted carbamates of 1-(2-hydroxyethyl)-3,5-diphenyl-1H-pyrazole and its 4-bromo derivative with depressant, antiarrhythmic, analgesic and other activities.
    Bondavalli F, Bruno O, Ranise A, Schenone P, Addonizio P, De Novellis V, Loffreda A, Marmo E.
    Farmaco Sci; 1988 Sep 01; 43(9):725-43. PubMed ID: 3229497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities.
    Bruno O, Ranise A, Bondavalli F, Schenone P, D'Amico M, Filippelli A, Filippelli W, Rossi F.
    Farmaco; 1993 Jul 01; 48(7):949-66. PubMed ID: 8397678
    [Abstract] [Full Text] [Related]

  • 10. 3,5-Diphenyl-1H-pyrazole derivatives. XII. N-substituted 4-amino-1-(2-hydroxy- or 2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazoles with local anesthetic, analgesic and platelet antiaggregating activities.
    Bruno O, Ranise A, Bondavalli F, Schenone S, D'Amico M, Falciani M, Vacca C, Filippelli A.
    Farmaco; 1994 Sep 01; 49(9):533-40. PubMed ID: 7811347
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
    Viveka S, Dinesha, Shama P, Nagaraja GK, Ballav S, Kerkar S.
    Eur J Med Chem; 2015 Aug 28; 101():442-51. PubMed ID: 26186150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antibacterial activity, quantitative structure-activity relationship and diastereoselective synthesis of isoxazolidine derivatives via 1,3-dipolar cycloaddition of d-glucose derived nitrone with olefin.
    Damodiran M, Sivakumar PM, Senthilkumar R, Muralidharan D, Phani Kumar BV, Doble M, Perumal PT.
    Chem Biol Drug Des; 2009 Nov 28; 74(5):494-506. PubMed ID: 19793183
    [Abstract] [Full Text] [Related]

  • 14. Efficient synthesis of trisubstituted pyrazoles and isoxazoles using a traceless "catch and release" solid-phase strategy.
    Ma W, Peterson B, Kelson A, Laborde E.
    J Comb Chem; 2009 Nov 28; 11(4):697-703. PubMed ID: 19459688
    [Abstract] [Full Text] [Related]

  • 15. Direct synthesis of polysubstituted aluminoisoxazoles and pyrazoles by a metalative cyclization.
    Jackowski O, Lecourt T, Micouin L.
    Org Lett; 2011 Oct 21; 13(20):5664-7. PubMed ID: 21942717
    [Abstract] [Full Text] [Related]

  • 16. 4-Alkoxycarbonyl- and aminocarbonyl-substituted isoxazoles as masked acrylates and acrylamides in the asymmetric synthesis of delta2-isoxazolines.
    Lee CK, Herlt AJ, Simpson GW, Willis AC, Easton CJ.
    J Org Chem; 2006 Apr 14; 71(8):3221-31. PubMed ID: 16599621
    [Abstract] [Full Text] [Related]

  • 17. Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.
    Quan ML, Lam PY, Han Q, Pinto DJ, He MY, Li R, Ellis CD, Clark CG, Teleha CA, Sun JH, Alexander RS, Bai S, Luettgen JM, Knabb RM, Wong PC, Wexler RR.
    J Med Chem; 2005 Mar 24; 48(6):1729-44. PubMed ID: 15771420
    [Abstract] [Full Text] [Related]

  • 18. 3,5-Diphenyl-1H-pyrazole derivatives. V--1-Acetyl-4-hydroxy-3,5-diphenyl-2-pyrazoline esters, 4-hydroxy-3,5-diphenyl-1H-pyrazole esters and N-substituted 4-(3-amino-2-hydroxy-1-propoxy)-1-methyl-3,5-diphenyl-1H-pyrazoles with antiarrhythmic, sedative and platelet antiaggregating activities.
    Bruno O, Bondavalli F, Ranise A, Schenone P, Losasso C, Cilenti L, Matera C, Marmo E.
    Farmaco; 1990 Feb 24; 45(2):147-66. PubMed ID: 2133992
    [Abstract] [Full Text] [Related]

  • 19. Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors.
    Nakamura T, Sato M, Kakinuma H, Miyata N, Taniguchi K, Bando K, Koda A, Kameo K.
    J Med Chem; 2003 Dec 04; 46(25):5416-27. PubMed ID: 14640550
    [Abstract] [Full Text] [Related]

  • 20. 3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.
    Yang J, Gharagozloo P, Yao J, Ilyin VI, Carter RB, Nguyen P, Robledo S, Woodward RM, Hogenkamp DJ.
    J Med Chem; 2004 Mar 11; 47(6):1547-52. PubMed ID: 14998340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.